VSee Health 3Q 2026: Revenue $1.5M, EPS ($3.88) — 10-Q Summary
VSee Health reported 3Q 2026 revenue of $1.5M, down 35% YoY, and a net loss of $2.85M, widened from $289.75K. EPS was ($3.88). The decline was driven by a shift to lower-margin teleradiology and contract expirations in Tele-ICU and Virtual Neuro services.
How this was made

The 30-second read
Why it matters
The key trading takeaway is that the quarter’s profitability deterioration is attributed to a shift toward lower-margin teleradiology and the expiration of specific Neuro ICU and inpatient contracts, which can reset expectations for future gross margin and revenue trajectory.
Market read
For traders, the disclosed quarter metrics and stated drivers (mix shift and contract expirations) are actionable for reassessing near-term revenue and margin expectations.
What to watch
The summary does not quantify pipeline, renewal timing, or cost actions; traders may be over-weighting the gross margin drop without seeing whether teleradiology margins are improving or stabilizing.
Background
The article is a brief 10-Q summary for VSee Health’s 3Q 2026 results, emphasizing revenue decline, net loss widening, and gross margin compression tied to service mix and contract expirations.
Ticker impact
VSee Health reported 3Q 2026 revenue of $1.5M, down 35.5% YoY, with gross margin falling to 21% from 48% due to mix shift.
Likely downside pressure as investors reprice the durability of gross margin and the revenue base after contract expirations.
The filing summary provides concrete quarter metrics (revenue, net loss, EPS, gross margin) and explains the drivers (contract expirations and service mix), which typically matter for near-term valuation and expectations.
Market effects
Highlights margin sensitivity in telehealth services to contract renewals and service mix, which can affect sentiment toward similar providers.
No specific regional market linkage stated beyond US contract expirations.
Limited, as the disclosure is company-specific and not tied to global macro or cross-border demand.
Counterpoint
The revenue decline is partly explained by specific contract expirations and non-recurring insurance billings, so results may be less indicative of underlying unit economics if new contracts replace the lost revenue.
Key entities
- companyVSee Health, Inc.
Telehealth services provider reporting 3Q 2026 revenue decline, widening net loss, and gross margin compression in its 10-Q summary.
